MEDICAL TOXICOLOGY FOUNDATION

Operates the Journal of Medical Toxicology, an international, peer-reviewed, Medline-indexed publication that advances the science and practice of medical toxicology through original research, case reports, and review articles.

Operates the Journal of Medical Toxicology, an international, peer-reviewed, Medline-indexed publication that advances the science and practice of medical toxicology through original research, case reports, and review articles.

Operates the Journal of Medical Toxicology, an international, peer-reviewed, Medline-indexed publication that advances the science and practice of medical toxicology through original research, case reports, and review articles.

Operates the Journal of Medical Toxicology, an international, peer-reviewed, Medline-indexed publication that advances the science and practice of medical toxicology through original research, case reports, and review articles.

Supports research projects that lead to advancements in medical toxicology and publications in national and international research journals.

Supported research on smartwatch technology to detect cannabis intoxication in real-time.

Supports research initiatives in medical toxicology, including studies on smartwatch detection of cannabis intoxication, opioid antagonist effectiveness in pre-hospital settings (RENDOR), and trends in synthetic opioid use through multi-site collaborations, resulting in publications in national and international journals.

Supports research projects that lead to advancements in medical toxicology and publications in national and international research journals, including studies on smartwatch technology for cannabis intoxication detection and the use of opioid antagonists.

Supports research projects that lead to advancements in medical toxicology and publications in national and international research journals, including studies on smartwatch technology for cannabis intoxication, opioid antagonists, novel synthetic opioids, and psilocybin use.

Offers capacity-building opportunities such as travel awards for medical toxicologists to attend the ACMT Annual Scientific Meeting and a fellowship rotation in industry program to expand training and career pathways in medical toxicology.

Offers a fellowship rotation in industry program for medical toxicologists.

Provides a fellowship rotation in industry program specifically for medical toxicologists.

Provides the Dr. Carol R. Angle Pediatric Toxicology Travel Award to encourage pediatric residents and medical students to pursue Medical Toxicology fellowship training.

Provides travel awards for medical toxicologists to attend ACMT’s Annual Scientific Meeting, encouraging early interest in the field and supporting participation from various groups including residents, students, and international authors.

Offers various travel awards (including general, pediatric, resident, student, and international) to medical toxicologists, residents, and students to attend ACMT’s Annual Scientific Meeting, encouraging early interest and career development in medical toxicology.

Provides travel awards for medical toxicologists to attend ACMT’s Annual Scientific Meeting, encouraging early interest in the field.

Provides multiple travel award programs—including the Dr. Carol R. Angle Pediatric Toxicology Travel Award, Resident Travel Award, Abstract Travel Awards, and the Dr. Michael Shannon Travel Award—that cover registration, travel, and lodging for the ACMT Annual Scientific Meeting to support early-career engagement and diversity in medical toxicology.

Coordinates a network of geographically diverse sites to evaluate novel synthetic opioids of abuse and track regional trends in fentanyl analog overdoses, including studies on para-fluorofentanyl and disparities in outpatient treatment referrals for opioid overdose patients.

Maintains a Core Registry of patient cases formally evaluated and treated by medical toxicology physicians.

Operates the SCANNED Overdose Surveillance Program to monitor the U.S. drug market and maintains a Core Registry of patient cases formally evaluated and treated by medical toxicology physicians, as well as the North American Snakebite Registry (NASBR) for comprehensive data collection on snakebites.

Operates the SCANNED Overdose Surveillance Program, which uses advanced laboratory toxicology, emergency department data, and national drug-checking resources to monitor and research the evolving U.S. drug market.

Runs multiple national data collection and research programs including the SCANNED Overdose Surveillance Program, the North American Snakebite Registry (NASBR), and a Core Registry of patient cases treated by medical toxicologists to monitor drug trends, evaluate emerging toxins, and support epidemiological research.

Operates the SCANNED Overdose Surveillance Program, which uses advanced laboratory toxicology, emergency department data, and national drug-checking resources to monitor and research the evolving U.S. drug market.

Investigates the rise of psilocybin use in chocolate confections, vape cartridges, and gummy snacks, as documented in the ToxIC NOSE Report #21.

Conducts the RENDOR project to assess the use, risks, benefits, and effectiveness of opioid antagonists in reversing opioid overdoses in pre-hospital settings.

Operates the North American Snakebite Registry (NASBR), which is a comprehensive prospective data collection on snakebites in North America.